2 Reasons to Like JNJ and 1 to Stay Skeptical
Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.
Pharma Giant Johnson & Johnson (JNJ) Boosts U.S. Investments by 25%
American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Siemens Healthineers AG (OtherSEMHF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Johnson & Johnson (JNJ – Research ...
Johnson & Johnson is the latest pharma giant to court Trump with new investment plans
Johnson & Johnson (JNJ) is joining Eli Lilly (LLY) in attempting to court favor with President Donald Trump by announcing ...
Johnson & Johnson’s $55 billion US commitment begins with Eastern NC plant groundbreaking
Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...
EconoTimes8d
Johnson & Johnson to Invest $55 Billion in U.S. Manufacturing and R&D Expansion
Johnson Johnson (NYSE: JNJ) announced plans to invest over $55 billion in the United States over the next four years, ...
GlobeSt4d
Johnson & Johnson Commits $55B to U.S. Healthcare Expansion
According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various ...
WNCT on MSN7d
Governor Stein speaks on Johnson and Johnson facility groundbreaking in Wilson
On Friday, Governor Josh Stein will join Johnson and Johnson for the groundbreaking of their new facility in Wilson. This ...
BenefitsPRO9d
JPMorgan sued by employees over alleged inflated drug prices
Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...
The Globe and Mail17d
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)
and ANI Pharmaceuticals. ;'> The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Johnson & Johnson with a $168.27 average price target, a 0.5% upside from ...
pharmaphorum3d
Name change for Johnson & Johnson offshoot to Kenvue
In appraisal of Kenvue’s visual identity, the logo for the independent new company is said to represent Johnson & Johnson’s timelessness, while “allowing space for its iconic brands to have ...